Educational Webinars

In this webinar you will learn:

• Why some launches stall despite strong clinical data

• The difference between activity metrics and performance-driving KPIs

• Simple principles for building a launch KPI dashboard
   

For details & registration

In this webinar you will learn:

• How different planning structures (such as medical, brand, KOL, and sales plans) connect and interact in practice

• Where misalignment typically occurs and why it matters

• How Medical Affairs can position itself more strategically within cross-functional planning
   

For details & registration

In this webinar you will learn:

• The key principles behind pharmaceutical deal-making

• How the value of an asset is assessed at its current stage of development and how that value evolves as key clinical and regulatory milestones are achieved

• The fundamentals of risk-adjusted net present value (rNPV)

• How licensing deals are typically structured and how different deal components can be adjusted to support win-win outcomes
   

For details & registration

In this webinar you will learn:

• Why many current engagement approaches fail to resonate with HCPs

• The key building blocks of trust-based HCP engagement

• How to design a focused pilot that delivers meaningful insight

• Practical steps to scale engagement without increasing noise
   

For details & registration

In this webinar you will learn:

• Why analogue-based decision making is often deeply flawed

• The vastness of “analogue space”

• The impossibility of seeing what you actually need to see (such as net prices)

• The psychology behind why teams are drawn to bad analogues

• What works much better
   

Watch Webinar

In this webinar you will learn:

• What MFN pricing could mean in practice for global pricing and launch planning

• Where the real risks lie for global teams across US and European markets

• How different MFN policy scenarios could play out across markets

• Practical approaches to stress-test your plans and anticipate downstream impact

• How to build a more resilient, future-ready global launch strategy

Watch webinar

In this webinar you will learn:

• The impact of AI and digital saturation on information processing and behavioural patterns

• What current research reveals about cognitive overload, retention, and engagement

• How digital-native patients evaluate credibility and trust

• Why authenticity and storytelling are gaining strategic importance

Watch webinar

In this webinar you will:

• Understand why many congress investments fail to deliver lasting impact

• Recognise the engagement gap between pharma teams and HCP expectations

• Get introduced to a structured approach to pre-, during-, and post-congress engagement

• Gain practical insights you can immediately reflect on within your own organisation

• Benchmark your current congress approach against live industry feedback

Watch Webinar

In this webinar you will learn:

• Why AI cannot escape the need for value-for-money evidence

• How AI’s impact can be evaluated through the “quintuple aim” framework (patient outcomes, patient experience, clinician well-being, cost, and equity)

• How to assess value for money — and how these methods apply to AI

• What recent systematic reviews reveal about the cost-effectiveness of AI in healthcare

• Common shortcomings in current economic evaluations of AI solutions

• Why a full Health Technology Assessment of AI in healthcare is needed

Watch webinar

In this webinar you will learn:

• How AI is being applied — unevenly but increasingly — across BD workflows

• Practical AI use cases for in-licensing: search, monitoring, due diligence

• How AI can support out-licensing: partner identification, conference prep, negotiation readiness

• Examples of tools and approaches BD teams are trying today

• Key risks, limitations and common pitfalls

Watch webinar

In this webinar you will learn:

• The shifts in HCP behaviour that explain declining attention and content fatigue

• How to adopt a trust-based, inbound content model tailored for HCP needs

• What “discoverability” means today, including the role of search and AI tools

• Real-world examples of educational content that supports HCPs at the moment of need

Watch webinar

In this webinar you will learn:

• A clear, non-technical explanation of agents, how they differ from “just ChatGPT”, and where they fit in your current commercial tools and processes.

• A focused tour of high-impact use cases already feasible in pharma today: brand planning, content support and document retrieval, field coaching, and insight generation.

• How to choose a strong first use case, map the workflow, define the system prompt and the knowledge base, turning a business problem into a working agent without overcomplicating things.

• Open Q&A

Watch webinar

In this webinar you will learn:

• The evolving AI landscape in pharma and medical affairs

• Inside the AI toolbox: what’s possible (and what’s not)

• Real-world case studies of AI solutions in pharma

Watch webinar

In this webinar you will learn:

• How a “perfect” payer/prescriber interview should unfold, and why most interviews never achieve this.

• The evidence, through actual AI vs human case studies, that shows how AI-moderated interviews can significantly outperform human moderators.

• Outperformance means more insights and deeper insights that are measurable.

• The psychology of why human respondents give more depth and more honesty when talking to an AI moderator.

• What this means for the future of your pharma payer and prescriber research.

Watch Webinar

In this webinar you will learn:

• What is the biggest challenge faced by Medical Affairs?

• What is driving the evolution of Medical Affairs and how does it affect us?

• What are the key ambitions for Medical Affairs and what is its role in modern pharma?

• How can this roadmap help to develop a positive culture of Medical Affairs Excellence?

Watch Webinar

In this webinar you will learn:

• Where and how AI can be integrated in the market access process

• How AI-based tools can reduce time and resource demands in dossier writing

• What HTA bodies and payers really accept when it comes to AI-supported evidence

• Live demonstration of use cases in pricing, objection handling, and launch planning

Watch webinar

In this webinar you will learn:

• What we mean by Medical Affairs impact: Defining and understanding the concept

• The 5 pillars of Medical Affairs impact: A framework for driving success

• Different perspectives on impact: Short-term vs. long-term, micro vs. macro, internal vs. external

• Making your impact visible: Best practices for communicating value to internal stakeholders

Watch webinar

In this webinar you will learn how to optimally:

• Allocate resources in a country across brands in an agile way

• Allocate resources across tactics at brand level, ex ante and ex post

Watch Webinar

In this webinar you will learn:

• Simple alternatives to traditional conjoint methods that handle complex product profiles much more effectively

• Alternative approaches that require smaller sample sizes

• Leveraging the vast repository of over $50 million worth of published pharma conjoint studies

• Why (unfortunately) you cannot survey ChatGPT instead of doing conjoints (Harvard academics have tried!)

Watch Webinar

In this webinar you will learn:

• What is better and what is more accepted: comparative RWE versus indirect comparisons based on trials.

• Synthetic control groups and post-approval comparative RWE studies: How do they work?

• Existing guidance and guidelines for comparative RWE studies 

Watch Webinar

In this webinar you will learn:

• How to personalise portfolio strategy at a country level as a component of near-term portfolio planning

• How to align investment priorities when considering mid-term portfolio strategy  

• How to manage uncertainty in the context of portfolio planning for the long term

Watch Webinar

In this webinar you will learn:

• Overview of the pharmaceutical value chain, a simple but powerful framework

• How BD&L activities help leverage strengths and address weaknesses across the full value chain

• Application of the value chain framework to assess strengths and weaknesses at each stage of the BD&L process

Watch Webinar

In this webinar you will learn:

• Using AI and/or econometrics to analyse past payer behaviour. Because, for payers, sometimes “actions speak louder than words”.

• Using meta-analysis to uncover powerful predictions from the mountain of published research papers.

• Using simulators of “virtual negotiations” to understand innovative contracting schemes from your and payers’ perspectives.

Watch Webinar

In this webinar you will learn:

• How to talk about value for money to clinicians and patient advocacy groups

• How to align the clinical and the health economic view

• How to go beyond the QALY to account for what matters to patients

• How to deal with evidence gaps: the increasing role of Real World Evidence 

Watch Webinar

In this webinar you will learn:

• The key ways that cell and gene therapy do and do not differ from more “conventional” therapies.

• The commercial significance of the fact that cell and gene therapies invariably enter the market with “one foot still in the lab” (i.e. with immature clinical data).

• The vital importance of “hope-based therapy” (high levels of uncertainty) rather than “evidence-based therapy” and how customers (payers/prescribers) actually act when faced with these uncertainties. 

• ...

Watch Webinar

In this webinar you will learn:

• The state of the art for measuring QALYs

• The value of a QALY

• Measuring health gains: beyond the QALY

Watch webinar